Abstract
The clinical usefulness of feprazone on lumbago was examined by the group comparison method, a double-blind controlled study dosing feprazone (300mg/day) and ibuprofen (600mg/day).As results, feprazone (300mg/day) showed the same extent of relief on lumbago as that of ibuprofen (600mg/day), which has already been recognized as a highly useful drug to control lumbago.In feprazone, as for safety, side effects, especially gastro-intestinal disorders, were slightly less than ibuprofen. Thus feprazone was concluded to be a commendable drug for the treatments of lumbago.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
